Moehler M - Search Results

1

FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial.

Heinemann V, von Weikersthal LF, Decker T, Kiani A, Kaiser F, Al-Batran SE, Heintges T, Lerchenmüller C, Kahl C, Seipelt G, Kullmann F, Moehler M, Scheithauer W, Held S, Miller-Phillips L, Modest DP, Jung A, Kirchner T, Stintzing S. Heinemann V, et al. Among authors: moehler m. Br J Cancer. 2021 Feb;124(3):587-594. doi: 10.1038/s41416-020-01140-9. Epub 2020 Nov 6. Br J Cancer. 2021. PMID: 33154570 Free PMC article. Clinical Trial.

2

18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil.

Moehler M, Dimitrakopoulou-Strauss A, Gutzler F, Raeth U, Strauss LG, Stremmel W. Moehler M, et al. Cancer. 1998 Jul 15;83(2):245-53. Cancer. 1998. PMID: 9669806

3

Safety and efficacy of outpatient treatment with CPT-11 plus bolus folinic acid/5-fluorouracil as first-line chemotherapy for metastatic colorectal cancer.

Moehler M, Hoffmann T, Zanke C, Hohl H, Burg H, Ehscheid P, Schwindt P, Adami B, Schroeder M, Klein O, Baldus M, Galle PR, Heike M. Moehler M, et al. Anticancer Drugs. 2003 Jan;14(1):79-85. doi: 10.1097/00001813-200301000-00011. Anticancer Drugs. 2003. PMID: 12544262

4

Comparison of a 48-hour infusion of 5-fluorouracil without folinic acid with 24-hour folinic acid/5-fluorouracil in patients with metastatic colorectal cancer refractory to bolus folinic acid/5-fluorouracil. A prospective cohort study.

Moehler M, Gutzler F, Steinmann S, Boehme M, Raeth U, Stremmel W, Galle PR, Rudi J. Moehler M, et al. Chemotherapy. 2003 May;49(1-2):85-9. doi: 10.1159/000069778. Chemotherapy. 2003. PMID: 12714817 Clinical Trial.

5

Weekly treatment with irinotecan, folinic acid and infusional 5-fluorouracil (ILF) in patients with advanced gastric cancer.

Moehler M, Haas U, Siebler J, Schimanski C, Hertkorn C, Hoehler T, Galle PR, Heike M. Moehler M, et al. Anticancer Drugs. 2003 Sep;14(8):645-50. doi: 10.1097/00001813-200309000-00010. Anticancer Drugs. 2003. PMID: 14501387 Clinical Trial.

6

Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer.

Teufel A, Steinmann S, Siebler J, Zanke C, Hohl H, Adami B, Schroeder M, Klein O, Höhler T, Galle PR, Heike M, Moehler M. Teufel A, et al. Among authors: moehler m. BMC Cancer. 2004 Jul 20;4:38. doi: 10.1186/1471-2407-4-38. BMC Cancer. 2004. PMID: 15265233 Free PMC article. Clinical Trial.

7

New chemotherapeutic strategies in colorectal cancer.

Moehler M, Teufel A, Galle PR. Moehler M, et al. Recent Results Cancer Res. 2005;165:250-9. doi: 10.1007/3-540-27449-9_28. Recent Results Cancer Res. 2005. PMID: 15865041 Review.

8

Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer.

Moehler M, Eimermacher A, Siebler J, Höhler T, Wein A, Menges M, Flieger D, Junginger T, Geer T, Gracien E, Galle PR, Heike M. Moehler M, et al. Br J Cancer. 2005 Jun 20;92(12):2122-8. doi: 10.1038/sj.bjc.6602649. Br J Cancer. 2005. PMID: 15942629 Free PMC article. Clinical Trial.

9

Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4.

Schimanski CC, Bahre R, Gockel I, Müller A, Frerichs K, Hörner V, Teufel A, Simiantonaki N, Biesterfeld S, Wehler T, Schuler M, Achenbach T, Junginger T, Galle PR, Moehler M. Schimanski CC, et al. Among authors: moehler m. Br J Cancer. 2006 Jul 17;95(2):210-7. doi: 10.1038/sj.bjc.6603251. Epub 2006 Jul 4. Br J Cancer. 2006. PMID: 16819541 Free PMC article.

10

Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report.

Sprinzl MF, Schimanski CC, Moehler M, Schadmand-Fischer S, Galle PR, Kanzler S. Sprinzl MF, et al. Among authors: moehler m. BMC Cancer. 2006 Jul 17;6:190. doi: 10.1186/1471-2407-6-190. BMC Cancer. 2006. PMID: 16846514 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

247 results

Search Page